Regulatory
KEY
Jun 3
— 0.00
Ernst & Young LLP consented to the incorporation by reference of its audit report for KeyCorp's consolidated financial statements across multiple Form S-3 and S-8 registration stat…
Regulatory
S3D
Jun 3
— 0.00
Sphere 3D's board adopted resolutions to establish a new series of unlimited Series I Preferred Shares, with rights and preferences to be determined. The filing relates to the comp…
Regulatory
SLM
Jun 3
— 0.00
The filing provides detailed characteristics and composition of the student loan trust portfolio as of April 30, 2026, including loan selection criteria and borrower statistics. Th…
Regulatory
SLM
Jun 3
— 0.00
The trust released detailed characteristics of its student loan pool as of April 30, 2026, including $1.3M in accrued interest and portfolio composition metrics. The disclosure pro…
Regulatory
OSUR
Jun 3
— 0.00
OraSure Technologies filed a certificate of amendment modifying its board of directors structure, transitioning from a staggered three-class system to single-year terms beginning i…
Regulatory
STEM
Jun 3
— 0.00
STEM, Inc. filed a second amended and restated 2024 equity incentive plan to govern employee, director and consultant stock awards including options, RSUs and restricted stock. The…
Regulatory
ADCT
Jun 3
▲ +0.65
ADC Therapeutics announced positive topline data from LOTIS-5 Phase 3 trial showing ZYNLONTA combined with rituximab achieved statistical significance on progression-free survival …
Regulatory
REED
Jun 3
▼ -0.80
Reed's Inc. received a notice from NYSE American on May 29, 2026, that the company is below compliance with listing standards due to stockholders' equity of $2.7 million and net lo…
Regulatory
FONAR
Jun 3
— 0.00
FONAR Corporation filed an amended and restated certificate of incorporation updating its Delaware corporate structure and governance provisions. The filing establishes standard di…
Regulatory
PNTL
Jun 3
— -0.10
Pineapple Financial Inc. has changed its certifying accountant, with MNP LLP consenting to the change filed in an 8-K on June 3, 2026. Auditor changes can signal accounting concern…
Regulatory
INMD
Jun 3
— 0.00
InspireMD increased its authorized shares to 255 million, consisting of 250 million common shares and 5 million preferred shares. The amendment was approved by stockholders and pro…
Regulatory
TECHLOTT
Jun 3
— 0.00
Techlott Inc. submitted an amended certificate of incorporation in SEC filing. The filing indicates a corporate governance or structural update to the company's charter documents.
Regulatory
KKR
Jun 3
— 0.00
KKR FS Income Trust executed a third amendment to its senior secured revolving credit facility with Sumitomo Mitsui Banking Corporation as administrative agent, dated May 28, 2026.…
Regulatory
EG
Jun 3
— 0.00
KPMG LLP provided consent for incorporating its February 26, 2026 audit report into Everest Group's S-3 and S-8 registration statements, with a June 3, 2026 date for segment report…
Regulatory
EZRA
Jun 3
▲ +0.65
Reliance Global Group's common stock regained compliance with Nasdaq's minimum $1.00 bid price requirement after trading at or above that level for 10 consecutive business days. Th…
Regulatory
SEII
Jun 3
— 0.00
Sharing Economy International Inc. filed an 8-K on May 28, 2026 disclosing an auditor change, with LAO Professionals confirming the accuracy of related statements. This confirms a …
Regulatory
REX
Jun 3
— 0.00
REX American Resources Corporation amended its certificate of incorporation to set total authorized shares at 90 million with $0.01 par value. The change allows the company flexibi…
Regulatory
SBEV
Jun 3
▼ -0.25
Splash Beverage submitted a compliance plan to NYSE American on May 28, 2026 to address stockholders' equity concerns, with potential cure period through January 29, 2027. The comp…
Regulatory
CRDF
Jun 3
▲ +0.50
Cardiff Oncology released interim results from its randomized Phase 2 CRDF-004 trial evaluating onvansertib combined with standard chemotherapy and bevacizumab for first-line RAS-m…
Regulatory
RNAZ
Jun 3
▲ +0.85
TransCode Therapeutics announced positive Phase 1a results for its lead candidate TTX-MC138, showing safety, tolerability, and disease stabilization in metastatic cancer patients a…